Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Arvinas.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Arvinas
Arvinas
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
New Haven, US HQ
Employees
Employees
188
Employees
13329% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
1.9 b

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$262.6m (FY, 2025)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($80.8m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company